» Articles » PMID: 12840067

Expansion of Human SCID-repopulating Cells Under Hypoxic Conditions

Overview
Journal J Clin Invest
Specialty General Medicine
Date 2003 Jul 4
PMID 12840067
Citations 122
Authors
Affiliations
Soon will be listed here.
Abstract

It has been proposed that bone marrow (BM) hematopoietic stem and progenitor cells are distributed along an oxygen (O2) gradient, where stem cells reside in the most hypoxic areas and proliferating progenitors are found in O2-rich areas. However, the effects of hypoxia on human hematopoietic stem cells (HSCs) have not been characterized. Our objective was to evaluate the functional and molecular responses of human BM progenitors and stem cells to hypoxic conditions. BM lineage-negative (Lin-) CD34+CD38- cells were cultured in serum-free medium under 1.5% O2 (hypoxia) or 20% O2 (normoxia) for 4 days. Using limiting dilution analysis, we demonstrate that the absolute number of SCID-repopulating cells (SRCs) increased by 5.8-fold in hypoxic cultures compared with normoxia, and by 4.2-fold compared with freshly isolated Lin-CD34+CD38- cells. The observed increase in BM-repopulating activity was associated with a preferential expansion of Lin-CD34+CD38- cells. We also demonstrate that, in response to hypoxia, hypoxia-inducible factor-1alpha protein was stabilized, surface expression of angiogenic receptors was upregulated, and VEGF secretion increased in BM Lin-CD34+ cultures. The use of low O2 levels to enhance the survival and/or self-renewal of human BM HSCs in vitro represents an important advance and could have valuable clinical implications.

Citing Articles

The Antioxidant TEMPOL Protects Human Hematopoietic Stem Cells From Culture-Mediated Loss of Functions.

Henry E, Picou F, Barroca V, Dechamps N, Sobrino S, Six E Stem Cells Transl Med. 2023; 12(10):676-688.

PMID: 37616262 PMC: 10552687. DOI: 10.1093/stcltm/szad049.


The quest for the holy grail: overcoming challenges in expanding human hematopoietic stem cells for clinical use.

Bastani S, Staal F, Cante-Barrett K Stem Cell Investig. 2023; 10:15.

PMID: 37457748 PMC: 10345135. DOI: 10.21037/sci-2023-016.


Transit Amplifying Cells (TACs): a still not fully understood cell population.

Cancedda R, Mastrogiacomo M Front Bioeng Biotechnol. 2023; 11:1189225.

PMID: 37229487 PMC: 10203484. DOI: 10.3389/fbioe.2023.1189225.


The hypoxia-inducible factor-1α in stemness and resistance to chemotherapy in gastric cancer: Future directions for therapeutic targeting.

Ozcan G Front Cell Dev Biol. 2023; 11:1082057.

PMID: 36846589 PMC: 9945545. DOI: 10.3389/fcell.2023.1082057.


Growth and adaptation mechanisms of tumour spheroids with time-dependent oxygen availability.

Murphy R, Gunasingh G, Haass N, Simpson M PLoS Comput Biol. 2023; 19(1):e1010833.

PMID: 36634128 PMC: 9876349. DOI: 10.1371/journal.pcbi.1010833.


References
1.
Ivanovic Z, Bartolozzi B, Bernabei P, Cipolleschi M, Rovida E, Milenkovic P . Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. Br J Haematol. 2000; 108(2):424-9. DOI: 10.1046/j.1365-2141.2000.01842.x. View

2.
Levy A, Levy N, Wegner S, Goldberg M . Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem. 1995; 270(22):13333-40. DOI: 10.1074/jbc.270.22.13333. View

3.
Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H . Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000; 105(7):1013-21. PMC: 377479. DOI: 10.1172/JCI8583. View

4.
Kollet O, Moore J, Aviram R, Liu B, Nagler A, Shultz L . The plant lectin FRIL supports prolonged in vitro maintenance of quiescent human cord blood CD34(+)CD38(-/low)/SCID repopulating stem cells. Exp Hematol. 2000; 28(6):726-36. DOI: 10.1016/s0301-472x(00)00163-6. View

5.
Ohh M, Park C, Ivan M, Hoffman M, Kim T, Huang L . Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat Cell Biol. 2000; 2(7):423-7. DOI: 10.1038/35017054. View